- Atorvastatin pretreatment, ST-segment resolution and long-term prognosis for ST-segment elevation myocardial infarction with primary percutaneous coronary intervention
IJC Heart & Vasculature · 2025
- Efficacy and Safety of Fimasartan, Atorvastatin, and Ezetimibe Combination Therapy in Patients With Hypertension and Dyslipidemia: A Randomized, Double-Blind, Multicenter, Therapeutic Confirmatory, Phase III Clinical Trial
Clinical Therapeutics · 2025
- High-Dose Statins Preserve Tendon-Bone Interface Healing Without Adversely Affecting Fatty Infiltration in a Rotator Cuff Repair Rat Model
Arthroscopy The Journal of Arthroscopic and Related Surgery · 2025
- Atrial Fibrillation in Advanced CKD
Kidney360 · 2025
- Secondary prevention using a statin with or without aspirin among Ghanaian intracerebral hemorrhage survivors: A feasibility randomized trial
Equity Neuroscience · 2025
- Predictive factors and pharmacological preventive interventions for atrial fibrillation after aortic valve replacement
Journal of Cardiothoracic Surgery · 2025
- Hospitalizations for bleeding associated with apixaban versus rivaroxaban according to dose in Medicare beneficiaries
Thrombosis Update · 2025
- Preclinical Assessment of Atorvastatin for Treatment of Endocardial Fibroelastosis
JACC Basic to Translational Science · 2025
- Comparative effectiveness and safety of atorvastatin versus rosuvastatin among patients with ischemic stroke or transient ischemic attack: a national registry-based observational study
EClinicalMedicine · 2025
- Rivaroxaban vs Warfarin in Acute Left Ventricular Thrombus Following Myocardial Infarction
JACC Advances · 2025
- Safety and effectiveness of Rivaroxaban, Dabigatran and Apixaban in patients with non-valvular atrial fibrillation for stroke prophylaxis
BMC Neurology · 2025
- PCSK9 Inhibitor Inclisiran Attenuates Cardiotoxicity Induced by Sequential Anthracycline and Trastuzumab Exposure via NLRP3 and MyD88 Pathway Inhibition
International Journal of Molecular Sciences · 2025
- The function of PCSK9 in doxorubicin-induced cardiotoxicity and its underlying mechanism
Scientific Reports · 2025
- <i>APOE</i> ε4 and Risk of Intracranial Hemorrhage in Patients With Atrial Fibrillation Taking Apixaban
JAMA Neurology · 2025
- Effectiveness and safety of rivaroxaban vs warfarin in patients with pulmonary embolism and right ventricular dysfunction: a retrospective cohort study
Research and Practice in Thrombosis and Haemostasis · 2025
- Efficacy and Safety of Low-Dose Rivaroxaban in High-Ischemic-Risk Patients with Chronic Coronary Syndrome: Rationale and Design of the DUTCH CCS Registry
Journal of Clinical Medicine · 2025
- STAREE-HEART: A randomized placebo-controlled trial of atorvastatin effects on a marker of cardiac aging in older individuals without prior cardiovascular disease events: Protocol and baseline description of participants
American Heart Journal · 2025
- Apixaban- and Rivaroxaban-Associated Bleeding: A Retrospective Analysis Using the FDA Adverse Event Reporting System
Cureus · 2025
- Safety of anticoagulation with apixaban following acute traumatic brain injury: A case series
World Neurosurgery X · 2025
- Predictors of major adverse cardiovascular events in ST-segment elevation myocardial infarction patients with high thrombus burden: a randomized clinical trial with echocardiographic and angiographic analysis
2025
- Antiplatelet and Anticoagulation Therapy for Peripheral Arterial Disease: Risks Versus Benefits
Cardiology in Review · 2025
- Blood pressure and antithrombotic in atrial fibrillation and coronary disease
2025
- Impact of a Physician-led Strike Early–Strike Strong Lipid-Lowering Protocol Incorporating PCSK9 Inhibitors for Patients with Acute Myocardial Infarction
Journal of Atherosclerosis and Thrombosis · 2025
- Outcomes of Different Regimens of Rivaroxaban and Aspirin in Cardiovascular Diseases: A Network Meta-Analysis
Journal of Clinical Medicine · 2025
- Periaortic Fat Attenuation on Nongated Noncontrast Chest CT Images to Assess Changes in Arterial Inflammation: Impact of Atorvastatin
Circulation Cardiovascular Imaging · 2025
- Short-term effects of PCSK-9 inhibitors on percutaneous coronary intervention in patients with acute coronary syndrome
The Korean Journal of Internal Medicine · 2025
- Comprehensive and robust stability-indicating reversed phase high performance liquid chromatography (RP-HPLC) method for Rivaroxaban: synergistic integration of infrared spectroscopy and clinical pharmacology insights
Frontiers in Chemistry · 2025
- Effectiveness of proprotein convertase subtilisin/kexin type 9 inhibitors in managing hypercholesterolemia post-statin-associated immune-mediated necrotizing myopathy: report of five cases and literature review
Rheumatology International · 2025
- Comment on<b> "</b>Apixaban <i>vs.</i> aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischemic attack: subgroup analysis of the ARTESiA randomized controlled trial"
Bleeding Thrombosis and Vascular Biology · 2025
- Dementia-related adverse events associated with direct oral anticoagulants use: a real-world, pharmacovigilance study based on the FAERS database
Expert Opinion on Drug Safety · 2025
- Apixaban for the treatment and secondary prevention of thrombotic complications in cancer patients with impaired renal function
Podderživaûŝaâ terapiâ v onkologii. · 2025
- Safety and effectiveness of proprotein convertase subtilisin/kexin type 9 inhibition: an updated review
Current Opinion in Lipidology · 2025
- Pharmacokinetics and Bioequivalence of Two Formulations of Apixaban Tablets: A Double-Blind, Single-Dose, Crossover Study in Healthy Subjects
Iranian journal of pharmaceutical research · 2025
- Analytical Methods for the Determination of Apixaban in Pharmaceuticals and Biological Matrices: A Systematic Review
Critical Reviews in Analytical Chemistry · 2025
- An Oral PCSK9 Inhibitor for Treatment of Hypercholesterolemia
Journal of the American College of Cardiology · 2025
- The Molecular and Clinical Impact of Atorvastatin Exposure on Paclitaxel Neurotoxicity in Sensory Neurons and Cancer Patients
Basic & Clinical Pharmacology & Toxicology · 2025
- The efficacy of atorvastatin on inflammation and coagulation markers in high-risk thrombotic cancer patients undergoing chemotherapy: a randomized controlled trial
Thrombosis Journal · 2025
- Regulatory effect of atorvastatin combined with berberine on PI3K/AKT/FoxO1 signaling pathway in rats with hyperlipidaemia
Xenobiotica · 2025
- Comparative clinical and laboratory study of rivaroxaban and its generic forms in patients with stable coronary artery disease
Russian Journal of Cardiology · 2025
- Cardioprotection During Myocardial Infarction in Diabetic Cardiomyopathy
Diabetes · 2025
- PCSK9 Promotes LDLR Degradation by Preventing SNX17-Mediated LDLR Recycling
Circulation · 2025
- The Role of Short-term Low-Dose Atorvastatin in Improving Endothelial Function in Normolipidemic Heart Failure with Preserved Ejection Fraction
Majallah-i dānishgāh-i ̒ulum-i pizishkī-i Kirmān. · 2025
- Coronary atherosclerotic plaque modification: the present and the future
Expert Review of Cardiovascular Therapy · 2025
- PCSK9 Enhances Cardiac Fibrogenesis via the Activation of Toll-like Receptor and NLRP3 Inflammasome Signaling
International Journal of Molecular Sciences · 2025
- A LASSO-derived model for the prediction of nonattainment of target LDL-C reduction with PCSK9 inhibitors in patients with atherosclerotic cardiovascular disease
Lipids in Health and Disease · 2025
- Real-World Efficacy and Safety of Apixaban vs. Warfarin in Obese Atrial Fibrillation Patients: Propensity Matching Analysis
Biomedicines · 2025
- Comparative Effectiveness of Rosuvastatin Versus Atorvastatin in Acute Ischemic Stroke Treatment
Journal of the American Heart Association · 2025
- Insights Into the Complexities of Antithrombotic Interactions: A Core–Shell Particle‐Based UHPLC–MS/MS Method to Investigate Dexamethasone's Influence on Apixaban and Rivaroxaban Pharmacokinetics
Separation Science Plus · 2025
- Safety and efficacy of edoxaban monotherapy after bioabsorbable polymer everolimus-eluting stent implantation in a human-like coronary atherosclerotic porcine model
Atherosclerosis Plus · 2025
- Molecular Therapeutics in Development to Treat Hyperlipoproteinemia
Molecular Diagnosis & Therapy · 2025